Nick Ede still shown as part of Management team, you would think that this would have been updated by now if he has left his position.
Dr Nick Ede | Head of Corporate DevelopmentDr Nick Ede has over 30 years’ peptide vaccine and drug development experience. He was formerly CEO of globally recognised peptide and drug development service company Mimotopes Pty Ltd. Prior to that he was VP Chemistry at Chiron Corp (now Novartis) heading medicinal and combinatorial chemistry programs, and was a Research Fellow with the CRC for Vaccine Technology pioneering infectious disease and cancer peptide vaccines.
DYOR opinion only
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
Nick Ede still shown as part of Management team, you would think...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.2¢ |
Change
0.001(1.96%) |
Mkt cap ! $373.3M |
Open | High | Low | Value | Volume |
5.1¢ | 5.3¢ | 5.0¢ | $448.4K | 8.727M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 415511 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 1004340 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 416173 | 0.051 |
42 | 2366453 | 0.050 |
27 | 2447673 | 0.049 |
19 | 1659400 | 0.048 |
12 | 1127463 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 1005153 | 10 |
0.053 | 1941674 | 7 |
0.054 | 2313294 | 7 |
0.055 | 1111417 | 11 |
0.056 | 353333 | 4 |
Last trade - 14.59pm 04/07/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |